Scientists hail new prostate cancer drug

Scientists hailed a new chemotherapy drug as the first ever treatment to prolong life for men with advanced prostate cancer.
By The Newsroom
Published 30th Sep 2010, 23:28 BST
Updated 30th Sep 2010, 23:28 BST

Researchers found those who trialled cabazitaxel in the latter, more aggressive stages of the disease, lived on average 30 per cent longer than those taking another medication.

The drug, which has been approved by the US Food and Drug

Administration (FDA), could offer an extra lease of life for thousands of men every year.

Hide Ad
Hide Ad

Cabazitaxel was tested on those with advanced prostate cancer who had developed a resistance to hormone treatment and the chemotherapy drug docetaxel.

The large-scale trial – led by Johann de Bono from The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust – was conducted in 146 trial sites in 26 countries around the world.